Stock Fundamentals

Company Information

Company Name
Silence Therapeutics PLC
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US82686Q1013
CIK: 0001479615
CUSIP: 82686Q101
Currency: USD
Full Time Employees: 88
Phone: 44 20 3457 6900
Fiscal Year End: December
IPO Date: Sep 08, 2020
Description:

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.

Address:

12 Hammersmith Grove, London, United Kingdom, W6 7AP

Directors & Officers

Name Title Year Born
Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D Interim CEO & Chairman of the Board 1954
Ms. Rhonda L. Hellums Executive VP, CFO, Secretary & Executive Director 1971
Dr. Steven J. Romano M.D. Executive VP and Chief Research & Development Officer 1959
Dr. Marie Wikstrom Lindholm Ph.D. Chief Scientific Officer NA
Ms. Gem Gokmen Hopkins Head of IR & Corporate Communications NA
Mr. Jaimin B. Shah SVP & General Counsel NA
Mr. J.P. Gabriel Chief Technical Operations Officer NA
Mr. Curtis Rambaran M.D. Chief Medical Officer NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
TCG Crossover Management, LLC 3.03M Mar 31, 2026 6.42% $0.46 0.00%
Siren, L.L.C. 2.91M Mar 31, 2026 6.16% $0.43 0.00%
Redmile Group, LLC 2.16M Mar 31, 2026 4.58% $0.76 0.00%
Nantahala Capital Management, LLC 2.15M Mar 31, 2026 4.54% $0.42 39.18%
Citadel Advisors Llc 1.23M Mar 31, 2026 2.61% $0.00 405.94%
Millennium Management LLC 1.07M Mar 31, 2026 2.27% $0.00 62.86%
Great Point Partners LLC 1.02M Mar 31, 2026 2.16% $1.24 26.29%
Nextech Invest, Ltd. 952.40K Dec 31, 2025 2.02% $0.56 0.00%
Ikarian Capital, LLC 865.78K Mar 31, 2026 1.83% $0.14 0.00%
Polygon Management Ltd 630.16K Mar 31, 2026 1.33% $0.64 72.47%
5AM Venture Management, LLC 476.20K Mar 31, 2026 1.01% $0.70 0.00%
SG Americas Securities, LLC 286.70K Mar 31, 2026 0.61% $0.00 11.84%
UBS Group AG 246.94K Mar 31, 2026 0.52% $0.00 19.00%
BOOTHBAY FUND MANAGEMENT, LLC 209.09K Mar 31, 2026 0.44% $0.01 0.00%
BlackRock Inc 204.78K Mar 31, 2026 0.43% $0.00 179.93%
Bank of Montreal 202.90K Mar 31, 2026 0.43% $0.00 26.44%
BMO Capital Markets Corp. 202.90K Mar 31, 2026 0.43% $0.00 26.44%
ADAR1 Capital Management LLC 172.16K Mar 31, 2026 0.36% $0.05 628.15%
Marshall Wace Asset Management Ltd 169.62K Mar 31, 2026 0.36% $0.00 8.95%
Seven Fleet Capital Management LP 156.76K Mar 31, 2026 0.33% $0.26 6.21%

Shares Statistics

Shares Outstanding: 47.23M
Shares Float: 74.75M
% Insiders: 2,437.70%
% Institutions: 4,441.30%
Short % Float: 5.56%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 International Biotechnology Ord 729.62K 1.54% ▲ 0.00% Feb 28, 2026
2 MEDICAL BioHealth EUR Acc 248.82K 0.53% ▼ 54.88% Apr 30, 2026
3 apo Medical Opportunities R 231.19K 0.49% ▼ 25.97% Mar 31, 2026
4 iShares Biotechnology ETF 170.79K 0.36% ▲ 0.64% Apr 30, 2026
5 RIM Global Bioscience EUR 147.96K 0.31% ▲ 8.83% Jan 31, 2026
6 Galileo - Biotech Innovation Fund S USD 58.65K 0.12% ▲ 0.00% Oct 31, 2025
7 iShares Nasdaq US Biotech ETF USD Acc 37.49K 0.08% ▲ 0.00% Apr 30, 2026
8 Vifag 2002 SICAV 30.00K 0.06% ▲ 0.00% Feb 28, 2026
9 Fidelity Nasdaq Composite Index 29.54K 0.06% ▲ 0.00% Mar 31, 2026
10 State Street® SPDR® S&P® Intl Sm Cp ETF 9.58K 0.02% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $80.26M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $300.88M
EBITDA: $-71.08M
Book Value: $1.32
Earnings/Share: $-1.62
Profit Margin: 0.00%
Operating Margin: -3,565.40%
ROA (TTM): -29.79%
ROE (TTM): -92.56%
Revenue (TTM): $839.00K
Revenue/Share (TTM): $0.02
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 197.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 8.72x 0.00x 0.53x N/A 0.00x
2024-12-31 11.14x 0.00x 0.34x N/A 0.00x
2023-12-31 4.62x 0.01x 0.82x -1,458.94x 0.00x
2022-12-31 4.41x 0.02x 0.79x -1,058.71x -0.01x
2021-12-31 5.69x 0.02x 0.91x -5,726.75x 0.00x
2020-12-31 2.99x 0.04x 0.89x -2,240.44x -0.01x
2019-12-31 3.88x 0.01x 0.55x -688.91x -0.01x
2018-12-31 7.70x 0.00x 0.10x -457.13x 0.00x
2017-12-31 17.14x 0.00x 0.05x -959.40x 0.00x
2016-12-31 26.09x 0.00x 0.03x -7.71x 0.00x
2015-12-31 47.90x 0.00x 0.02x -28.73x 0.00x
2014-12-31 11.05x 0.05x 0.07x -82.50x -0.12x
2013-12-31 12.34x 0.05x 0.06x -129.60x -0.14x
2012-12-31 9.45x 0.05x 0.06x -877.13x -0.16x
2011-12-31 3.10x 0.00x 0.04x -445.08x 0.00x
2010-12-31 2.60x 0.00x 0.05x -137.43x 0.00x
2009-12-31 0.83x 0.00x 0.19x -164.22x 0.00x
2008-12-31 4.73x 0.00x 0.07x -251.35x 0.00x
2007-12-31 6.46x 0.00x 0.09x -10.64x 0.00x
2006-12-31 9.23x 0.00x 0.06x -213.40x 0.00x
2005-12-31 7.20x 0.00x 0.09x -3,898.00x 0.00x
2004-12-31 6.13x 0.00x 0.27x -47.44x 0.00x
2003-12-31 4.92x 0.00x 0.20x -12.38x 0.00x
2002-12-31 8.19x 0.00x 0.12x -6.64x 0.00x
2001-12-31 13.24x 0.00x 0.07x -6.32x 0.00x
2000-12-31 12.46x 0.00x 0.08x -5.42x 0.00x
1999-12-31 6.74x 0.00x 0.15x -13.37x 0.00x
1998-12-31 6.54x 0.00x 0.15x -5.87x 0.00x
1997-12-31 8.18x 0.00x 0.12x -5.42x 0.00x
1996-12-31 16.17x 0.00x 0.06x -4.46x 0.00x
1995-12-31 10.17x 0.00x 0.10x -15.81x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SLN.US!